| Literature DB >> 31598376 |
Ki Bum Park1, Eun Young Kim2, Kyo Young Song1,2.
Abstract
PURPOSE: No standard technique has been established for esophagojejunal anastomosis during laparoscopic total gastrectomy (LTG) for gastric cancer owing to the technical difficulty and high complication rate of this procedure. This study was performed to compare the short-term outcomes of circular and linear stapling methods after LTG.Entities:
Keywords: Anastomosis, Roux-en-Y; Gastrectomy; Gastric cancer; Laparoscopy; Postoperative complication
Year: 2019 PMID: 31598376 PMCID: PMC6769364 DOI: 10.5230/jgc.2019.19.e34
Source DB: PubMed Journal: J Gastric Cancer ISSN: 1598-1320 Impact factor: 3.720
Fig. 1Flow diagram of the study.
LTG = laparoscopic total gastrectomy; TG = total gastrectomy; HDST = hemi-double-stapling technique.
Fig. 2Hemi-double-stapling technique. (A) A 3-cm vertical incision was made in the direction of the esophagus approximately 1–2 cm below the esophagogastric junction. (B) The anvil in the abdominal cavity was pushed into the opening using the anvil holder. (C) The thread tied to the central rod was held upward, and esophageal transection was performed using an Endo GIA™ linear stapler. (D) As the thread was subsequently pulled out, the central rod was pulled out of the esophageal stump. (E) The central rod was removed, and the anvil head and EEA™ stapler were connected. (F) Anastomosis between the jejunum and esophageal stump was performed.
Fig. 3Overlap method. (A) Esophageal transection was performed using an Endo GIA™ linear stapler, leaving about 1 cm of the left side of the esophagus attached. (B) The remaining 1-cm portion was resected using a harmonic scalpel to create an opening. (C) The true lumen of the esophageal stump was confirmed. (D) The jejunum was approximated to confirm the tension of the Roux limb. (E) Esophagojejunostomy was performed using an Endo GIA™ linear stapler. (F) The entry hole was closed in 2 layers using barbed sutures.
Clinicopathological characteristics and surgical outcomes in groups C and L
| Variables | Group C (n=77) | Group L (n=29) | P-value | |
|---|---|---|---|---|
| Sex | ||||
| Male | 50 (64.9) | 25 (86.2) | ||
| Female | 27 (35.1) | 4 (13.8) | ||
| Age (yr) | 57.5±11.5 | 56.8±14.6 | 0.785 | |
| Body mass index (kg/m2) | 23.7±3.3 | 23.7±3.1 | 0.992 | |
| Comorbidity | 0.227 | |||
| Absent | 35 (45.5) | 17 (58.6) | ||
| Present | 42 (54.5) | 12 (41.4) | ||
| Previous abdominal operation | 0.769 | |||
| Absent | 63 (81.8) | 23 (79.3) | ||
| Present | 14 (18.2) | 6 (20.7) | ||
| Duration of operation (min) | 200.8±32.9 | 199.0±45.4 | 0.555 | |
| Estimated blood loss (mL) | 109.8±91.0 | 132.1±156.2 | 0.243 | |
| Extent of lymph node dissection | 0.411 | |||
| D1 | 11 (14.3) | 7 (24.1) | ||
| D1+ | 52 (67.5) | 16 (55.2) | ||
| D2 | 14 (18.7) | 6 (20.7) | ||
| Tumor location | 0.967 | |||
| Esophageal gastric junction | 2 (2.6) | 1 (3.4) | ||
| Upper 1/3 | 38 (49.4) | 15 (51.7) | ||
| Middle 1/3 | 34 (44.2) | 12 (41.4) | ||
| Lower 1/3 | 3 (3.9) | 1 (3.4) | ||
| Pathological stage | ||||
| I | 68 (88.3) | 16 (55.2) | ||
| II | 5 (6.5) | 6 (20.7) | ||
| III | 4 (5.2) | 7 (24.1) | ||
Data are shown as mean±standard deviation or number (%).
Anastomotic complications in groups C and L
| Variables | Group C (n=77) | Group L (n=29) | P-value | ||
|---|---|---|---|---|---|
| Anastomotic complications | 20 (26.0) | 2 (6.9) | |||
| Leakage | 5 (6.5) | 2 (6.9) | 1.000 | ||
| I | 0 | 0 | |||
| II | 0 | 0 | |||
| IIIa | 5 (6.5) | 1 (3.4) | |||
| IIIb | 0 | 1 (3.4) | |||
| IV | 0 | 0 | |||
| V | 0 | 0 | |||
| Stricture | 13 (17.3) | 0 | |||
| I | 3 (4.0) | 0 | |||
| II | 0 | 0 | |||
| IIIa | 10 (13.3) | 0 | |||
| IIIb | 0 | 0 | |||
| IV | 0 | 0 | |||
| V | 0 | 0 | |||
| Bleeding | 2 (2.6) | 0 | 1.000 | ||
| I | 0 | 0 | |||
| II | 0 | 0 | |||
| IIIa | 1 (1.3) | 0 | |||
| IIIb | 0 | 0 | |||
| IV | 0 | 0 | |||
| V | 1 (1.3) | 0 | |||
Data are shown as number (%).
Roman numbers indicate the Clavien–Dindo classification grade.
Non-anastomotic complications in groups C and L
| Variables | Group C (n=77) | Group L (n=29) | P-value | ||
|---|---|---|---|---|---|
| Non-anastomotic complications | 21 (27.3) | 11 (37.9) | 0.287 | ||
| Systemic complications | 13.0 | 5 (17.2) | |||
| Death | 1 (1.3) | 1 (3.4) | |||
| Respiratory | 6 (7.8) | 3 (10.3) | |||
| Urinary | 3 (3.9) | 1 (3.4) | |||
| Local complications | 11 (14.3) | 6 (20.6) | |||
| Ileus | 3 (3.9) | 1 (3.4) | |||
| Internal hernia | 0 | 2 (6.8) | |||
| Intra-abdominal fluid collection | 4 (5.2) | 1 (3.4) | |||
| Pancreatitis | 1 (1.3) | 0 | |||
| Phlebitis | 0 | 2 (6.8) | |||
| Splenic vein bleeding | 1 (1.3) | 0 | |||
| Wound problem | 2 (2.6) | 0 | |||
Values are presented as number (%).
Multivariate analysis of risk factors for anastomotic complications
| Variables | Unadjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | |
|---|---|---|---|---|---|
| Age (yr) | - | - | |||
| ≤65 | Reference | - | |||
| >65 | 1.17 (0.39–3.58) | 0.778 | |||
| Sex | - | - | |||
| Male | Reference | - | |||
| Female | 1.18 (0.41–3.39) | 0.763 | |||
| Comorbidity | - | - | |||
| Absent | Reference | - | |||
| Present | 1.03 (0.34–3.07) | 0.963 | |||
| Type of anastomosis | |||||
| Overlap method | Reference | - | Reference | - | |
| HDST | 3.68 (0.74–18.29) | 0.111 | 4.74 (1.03–21.7) | ||
| Pathological stage | - | - | |||
| Stage I | Reference | - | |||
| Stage II and III | 0.49 (0.09–2.53) | 0.391 | |||
| Tumor location | - | - | |||
| Upper part of the stomach | Reference | - | |||
| Lower part of the stomach | 1.25 (0.47–3.34) | 0.662 | |||
| Lymph node dissection | - | - | |||
| D1 and D1+ | Reference | - | |||
| D2 | 1.12 (0.31–4.07) | 0.867 | |||
OR = odds ratio; CI = confidence interval; HDST = hemi-double-stapling technique.